华利安：2023年糖尿病管理行业焦点报告（英文版）（18页）.pdf

1、Diabetes ManagementSECTOR SPOTLIGHTSPR IN G 2023 Type 2(Insulin)Diabetes Market Overview(1)Type 1 diabetes is a genetic condition preventing the pancreas from producing sufficient levels of insulin and typically occurs at a young age.Type 2 diabetes is caused by insulin resistance,typically from poo

2、r lifestyle and diet,and develops at an older age.Sources:U.S.Census Bureau;UnitedHealthcare Group(2021 Report);CMS;CDC.Diabetes is one of the fastest-growing,most pervasive,and costliest chronic diseases in the U.S.,with an estimated total annual economic impact of$327 billion.2Increasing Prevalenc

3、e of DiabetesType 2 diabetes patients represent an outsized portion of the diabetic patient population and market sizeRising,Unsustainable Cost Burden for the Healthcare SystemDiabetes poses a significant financial burden on the U.S.healthcare system and broader economy,with a total estimated econom

4、ic cost of$327 billion,including$237 billion of direct medical costs and$90 billion of indirect costs20.824.928.95.66.67.71.51.71.927.933.138.42017A2022E2027PType 2(Non-Insulin)Type 1 U.S.Diagnosed Diabetic Population by Condition Type,in Millions(1)Economic Impact of Diabetes in the U.S.Average Ann

5、ual Cost for Patients With Chronic Conditions$327B$237BTotal economic costDirect medical costsIndirect costs$90B$2,100$5,800$11,000$30,100-$5,000$10,000$15,000$20,000$25,000$30,000$35,000Only Condition1-2 Other Conditions3-4 Other Conditions5+Other ConditionsDiabetes OnlyDiabetes and 12 Other Chroni

6、c ConditionsDiabetes and 5+Other Chronic ConditionsDiabetes and 34 Other Chronic ConditionsWeighted Average:$10,100 No near-term cure for diabetes is expected Poor diet and lifestyle habits are expected to continue to drive growth in the Type 2 population Type 2(insulin)and Type 2(non-insulin)diabet